WS #8638

The dominant theme remains the escalation of the Israel-Lebanon conflict, with new reports of Israeli airstrikes hitting Tyre, Nabatieh, and Babliyeh in southern Lebanon, and Hezbollah retaliating with rockets at Kiryat Shmona. Israeli media reports Netanyahu is leaning toward expanding strikes across Lebanon, and an Israeli strike near a hospital wounded 13 staffers. This is a clear escalation despite nominal ceasefire claims. The oil supply crisis is deepening: IEA warns global oil reserves are being depleted at record pace, with 14 million barrels/day offline due to the Strait of Hormuz blockade, and experts warn of a critical phase in weeks. This supports a bullish oil thesis. On the positive side, the US extended the deadline for Lukoil asset sales to June 27, allowing negotiations to continue, which could be a minor counter-signal. The US-Iran deal narrative remains mixed: Trump says he's in no rush and is slowly imposing terms, while Iran claims to have shot down a US MQ-1 drone. The Shangri-La Dialogue in Singapore featured US Defense Secretary Hegseth warning against Chinese hegemony and criticizing Europe, but also noting US-China relations are 'better than in many years'. In healthcare, Eli Lilly's Retevmo significantly reduced lung cancer recurrence risk, and a novel pancreatic cancer pill (daraxonrasib) nearly doubled survival time, both positive for biotech. The Nasdaq 100 forecast remains bullish above 30,000 on AI momentum. The MAG7 narrative is stable with no contradicting signals, though IBM stock surged nearly 19% on a $15B quantum computing and AI security initiative. The Ebola outbreak in DRC and Uganda has 263 confirmed cases and 43 deaths, with over 1,100 suspected cases still under investigation, which could be a low-probability but high-impact risk for travel and consumer sectors if it spreads.